LexDanaLexDanabeta
Inventor

JOHN H. VAN DUZER

Inventor
US

Overview

4→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds10%
PatentTitleYear
11,858,919HDAC1,2 inhibitors202411,702,389Piperidine derivatives as HDAC1/2 inhibitors202311,617,750Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof202311,542,242Substituted piperazines as selective HDAC1,2 inhibitors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to REGENACY PHARMACEUTICALS LLC (3)· patent assignee history
2023–2024Patents assigned to REGENACY PHARMACEUTICALS INC (2)· patent assignee history
2023Patents assigned to ACETYLON PHARMACEUTICALS INC (1)· patent assignee history
2023–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENACY PHARMACEUTICALS LLC32023–2024
REGENACY PHARMACEUTICALS INC22023–2024
ACETYLON PHARMACEUTICALS INC12023
Locations
LocationPatentsSpan
US42023–2024